Cargando…
Current trends in the pharmacological management of Chagas disease
Chagas disease (CD) is a tropical neglected illness, affecting mainly populations of low socioeconomic status in Latin America. An estimated 6 to 8 million people worldwide are infected with Trypanosoma cruzi, the etiological agent of CD. Despite being one of the main global health problems, this di...
Autores principales: | Ribeiro, Vanessa, Dias, Nayra, Paiva, Taís, Hagström-Bex, Luciana, Nitz, Nadjar, Pratesi, Riccardo, Hecht, Mariana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928327/ https://www.ncbi.nlm.nih.gov/pubmed/31862616 http://dx.doi.org/10.1016/j.ijpddr.2019.11.004 |
Ejemplares similares
-
Correlation of Parasite Burden, kDNA Integration, Autoreactive Antibodies, and Cytokine Pattern in the Pathophysiology of Chagas Disease
por: Wesley, Moisés, et al.
Publicado: (2019) -
Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
por: Teixeira, Antonio R. L., et al.
Publicado: (2012) -
Insights from the use of erythropoietin in experimental Chagas disease
por: de Castro Nobre, Ana Carolina, et al.
Publicado: (2022) -
Seroprevalence of Trypanosoma cruzi in pregnant women in Midwest Brazil: an evaluation of congenital transmission
por: Nobre, Tayane, et al.
Publicado: (2021) -
Surveillance of vector-borne pathogens under imperfect detection: lessons from Chagas disease risk (mis)measurement
por: Minuzzi-Souza, Thaís Tâmara Castro, et al.
Publicado: (2018)